Revisions of 'Germinal matrix hemorrhage - grade IV'

• Revision 4 - created almost 2 years ago by Mostafa Elfeky ◉ - view changeset
  Date: 2023-02-14 17:04:47 UTC Disclosures:

  At the time the revision was created Mostafa Elfeky had no financial relationships to ineligible companies to disclose.

  View Mostafa Elfeky's current disclosures Reviewed by: Jeremy Jones
• Revision 3 - created almost 2 years ago by Ryan Thibodeau ◉ - view changeset
  Date: 2023-02-10 14:58:04 UTC Disclosures:

  At the time the revision was created Ryan Thibodeau had no financial relationships to ineligible companies to disclose.

  View Ryan Thibodeau's current disclosures Reviewed by: Jeremy Jones
• Revision 2 - created almost 2 years ago by Henry Knipe ◉ - view changeset
  Date: 2023-02-09 00:55:55 UTC Disclosures:

  At the time the revision was created Henry Knipe had the following disclosures:

  • Integral Diagnostics, Shareholder (ongoing)
  • Micro-X Ltd, Shareholder (ongoing)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Henry Knipe's current disclosures Reviewed by: Joachim Feger
• Revision 1 - created almost 2 years ago by Ryan Thibodeau ◉ - view changeset
  Date: 2023-02-08 21:48:51 UTC Disclosures:

  At the time the revision was created Ryan Thibodeau had no financial relationships to ineligible companies to disclose.

  View Ryan Thibodeau's current disclosures Reviewed by: Mostafa Elfeky

Unfortunately some older revisions may not be able to be viewed or restored.